Immune response in Leukodystrophies

被引:33
作者
Eichler, Florian [1 ]
Van Haren, Keith [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
关键词
D O I
10.1016/j.pediatrneurol.2007.06.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although the genetics and biochemistry of leukodystrophies have been extensively explored, the immune response in these disorders has received relatively little attention. Both the disease course and its response to treatment may be highly dependent on the immune system. In this review, we compare three common leukodystrophies, each with a different immune response: (1) X-linked adrenoleukodystrophy, which demonstrates a severe, lymphocytic inflammatory response; (2) metachromatic leukodystrophy, which yields a histiocytic response; and (3) vanishing whitematter disease, in which no inflammation is typically seen. We highlight the biochemical, pathologic, and clinical differences, while focusing on the immune response in each disease. We also review the response of leukodystrophies to immunomodulatory therapies and interventions such as hematopoietic stem-cell transplantation. Future studies may delineate specific inflammatory markers as possible candidates for therapeutic intervention. (c) 2007 by Elsevier Inc. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 96 条
[1]   MRI DETECTS CEREBRAL INVOLVEMENT IN NEUROLOGICALLY ASYMPTOMATIC PATIENTS WITH ADRENOLEUKODYSTROPHY [J].
AUBOURG, P ;
SELLIER, N ;
CHAUSSAIN, JL ;
KALIFA, G .
NEUROLOGY, 1989, 39 (12) :1619-1621
[2]  
AUSTIN JH, 1959, P SOC EXP BIOL MED, V100, P361
[3]   The microglial cell. A historical review [J].
Barron, KD .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 134 :57-68
[4]   Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening [J].
Bezman, L ;
Moser, AB ;
Raymond, GV ;
Rinaldo, P ;
Watkins, PA ;
Smith, KD ;
Kass, NE ;
Moser, HW .
ANNALS OF NEUROLOGY, 2001, 49 (04) :512-517
[5]   Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells [J].
Biffi, A ;
De Palma, M ;
Quattrini, A ;
Del Carro, U ;
Amadio, S ;
Visigalli, I ;
Sessa, M ;
Fasano, S ;
Brambilla, R ;
Marchesini, S ;
Bordignon, C ;
Naldini, L .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (08) :1118-1129
[6]   HIGH-DOSE IMMUNOGLOBULIN IV TREATMENT IN ADRENOLEUKODYSTROPHY [J].
CAPPA, M ;
BERTINI, E ;
DELBALZO, P ;
CAMBIASO, P ;
DIBIASE, A ;
SALVATI, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 :69-70
[7]  
Clemens MJ, 2001, PROG MOLEC, V27, P57
[8]   The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases [J].
Cosma, MP ;
Pepe, S ;
Annunziata, I ;
Newbold, RF ;
Grompe, M ;
Parenti, G ;
Ballabio, A .
CELL, 2003, 113 (04) :445-456
[9]   METABOLISM OF CELLULAR MEMBRANE SULPHOLIPIDS IN RAT BRAIN [J].
DAVISON, AN ;
GREGSON, NA .
BIOCHEMICAL JOURNAL, 1966, 98 (03) :915-&
[10]   EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy [J].
Dietrich, J ;
Lacagnina, M ;
Gass, D ;
Richfield, E ;
Mayer-Pröschel, M ;
Noble, M ;
Torres, C ;
Pröschel, C .
NATURE MEDICINE, 2005, 11 (03) :277-283